These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Mycobacterium ulcerans in the Daintree 2009-2015 and the mini-epidemic of 2011. Steffen CM; Freeborn H ANZ J Surg; 2018 Apr; 88(4):E289-E293. PubMed ID: 27804194 [TBL] [Abstract][Full Text] [Related]
9. [Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana]. Sambourg E; Dufour J; Edouard S; Morris A; Mosnier E; Reynaud Y; Sainte-Marie D; Nacher M; Guégan JF; Couppié P Ann Dermatol Venereol; 2014; 141(6-7):413-8. PubMed ID: 24951139 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology, clinical features and diagnosis of Mycobacterium ulcerans in an Australian population. Boyd SC; Athan E; Friedman ND; Hughes A; Walton A; Callan P; McDonald A; O'Brien DP Med J Aust; 2012 Mar; 196(5):341-4. PubMed ID: 22432674 [TBL] [Abstract][Full Text] [Related]
12. Clinical features and management of a severe paradoxical reaction associated with combined treatment of Buruli ulcer and HIV co-infection. Wanda F; Nkemenang P; Ehounou G; Tchaton M; Comte E; Toutous Trellu L; Masouyé I; Christinet V; O'Brien DP BMC Infect Dis; 2014 Jul; 14():423. PubMed ID: 25073531 [TBL] [Abstract][Full Text] [Related]
13. Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort. Friedman ND; Athan E; Walton AL; O'Brien DP Antimicrob Agents Chemother; 2016 May; 60(5):2692-5. PubMed ID: 26883709 [TBL] [Abstract][Full Text] [Related]
14. Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease). Kibadi K; Boelaert M; Fraga AG; Kayinua M; Longatto-Filho A; Minuku JB; Mputu-Yamba JB; Muyembe-Tamfum JJ; Pedrosa J; Roux JJ; Meyers WM; Portaels F PLoS Negl Trop Dis; 2010 Jul; 4(7):e736. PubMed ID: 20625556 [TBL] [Abstract][Full Text] [Related]
15. Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load. Frimpong M; Agbavor B; Duah MS; Loglo A; Sarpong FN; Boakye-Appiah J; Abass KM; Dongyele M; Amofa G; Tuah W; Frempong M; Amoako YA; Wansbrough-Jones M; Phillips RO PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007689. PubMed ID: 31449522 [TBL] [Abstract][Full Text] [Related]
16. Six vs Eight Weeks of Antibiotics for Small Mycobacterium ulcerans Lesions in Australian Patients. O'Brien DP; Friedman ND; Cowan R; Walton A; Athan E Clin Infect Dis; 2020 Apr; 70(9):1993-1997. PubMed ID: 31231766 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for recurrent Mycobacterium ulcerans disease after exclusive surgical treatment in an Australian cohort. O'Brien DP; Walton A; Hughes AJ; Friedman ND; McDonald A; Callan P; Rhadon R; Holten I; Athan E Med J Aust; 2013 May; 198(8):436-9. PubMed ID: 23641995 [TBL] [Abstract][Full Text] [Related]
18. "Paradoxical" immune-mediated reactions to Mycobacterium ulcerans during antibiotic treatment: a result of treatment success, not failure. O'Brien DP; Robson ME; Callan PP; McDonald AH Med J Aust; 2009 Nov; 191(10):564-6. PubMed ID: 19912091 [TBL] [Abstract][Full Text] [Related]